Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$27,000.00
Maternal Placental Crosstalk: Investigating Iron Dysregulation in Maternal Cardiomyopathy of Preeclampsia
EF 2024-25
Résumé
Preeclampsia (PE) is a hypertensive disorder linked to abnormal placentation and maternal cardiovascular abnormalities. Our lab demonstrated that preeclamptic dams in a transgenic murine model develop left ventricular cardiomyopathy. Placental-derived small extracellular vesicles (sEVs), containing bioactive cargo like lipid peroxidation precursors and acid sphingomyelinase (SMPD1), enter maternal circulation. SMPD1 converts sphingomyelin into ceramides, which promote autophagic degradation of glutathione peroxidase 4 (GPx4), an antioxidant crucial for preventing lipid peroxidation. This degradation drives ferroptosis, an iron-dependent programmed cell death, suggesting a role in maternal cardiomyopathy in PE. Hypothesis: Placental sEV cargo, particularly SMPD1, increases maternal heart ferroptosis via GPx4 degradation. I will investigate placental sEV effects on maternal cardiac iron homeostasis and ferroptosis in human cardiomyocyte, and evaluate SMPD1 inhibitors for mitigating ferroptosis. Methods: Human ventricular cardiomyocytes were treated under simulated PE conditions: hypoxia, iron overload, synthetic ceramides, and sEVs from PE and normotensive pregnancies. Additionally, cardiomyocytes were treated with Zoledronic Acid (ZA), an SMPD1 inhibitor, and autophagy inhibitors (3-MA, Bafilomycin) to study SMPD1-mediated GPx4 degradation. Ferroptosis was assessed by quantifying SMPD1/GPx4 (Western blot), oxidative stress (MDA ELISA), ROS detection (BODIPY-11 imaging), and iron/GPx4 activity (colorimetric assays). Preliminary findings: FAC treatment increased SMPD1 and decreased GPx4 levels. Preeclamptic sEVs raised SMPD1. ZA increased SMPD1 protein, suggesting compensatory upregulation for reduced activity.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
530184
Name
Feldman Mia S
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Maternal Placental Crosstalk: Investigating Iron Dysregulation in Maternal Cardiomyopathy of Preeclampsia
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cardiomyopathy; Ferroptosis; Hypertension; In Vitro Models; Mouse Models; Placenta; Preeclampsia; Pregnancy; Small Extracellular Vesicles; Women'S Health
Abstract
Preeclampsia (PE) is a hypertensive disorder linked to abnormal placentation and maternal cardiovascular abnormalities. Our lab demonstrated that preeclamptic dams in a transgenic murine model develop left ventricular cardiomyopathy. Placental-derived small extracellular vesicles (sEVs), containing bioactive cargo like lipid peroxidation precursors and acid sphingomyelinase (SMPD1), enter maternal circulation. SMPD1 converts sphingomyelin into ceramides, which promote autophagic degradation of glutathione peroxidase 4 (GPx4), an antioxidant crucial for preventing lipid peroxidation. This degradation drives ferroptosis, an iron-dependent programmed cell death, suggesting a role in maternal cardiomyopathy in PE. Hypothesis: Placental sEV cargo, particularly SMPD1, increases maternal heart ferroptosis via GPx4 degradation. I will investigate placental sEV effects on maternal cardiac iron homeostasis and ferroptosis in human cardiomyocyte, and evaluate SMPD1 inhibitors for mitigating ferroptosis. Methods: Human ventricular cardiomyocytes were treated under simulated PE conditions: hypoxia, iron overload, synthetic ceramides, and sEVs from PE and normotensive pregnancies. Additionally, cardiomyocytes were treated with Zoledronic Acid (ZA), an SMPD1 inhibitor, and autophagy inhibitors (3-MA, Bafilomycin) to study SMPD1-mediated GPx4 degradation. Ferroptosis was assessed by quantifying SMPD1/GPx4 (Western blot), oxidative stress (MDA ELISA), ROS detection (BODIPY-11 imaging), and iron/GPx4 activity (colorimetric assays). Preliminary findings: FAC treatment increased SMPD1 and decreased GPx4 levels. Preeclamptic sEVs raised SMPD1. ZA increased SMPD1 protein, suggesting compensatory upregulation for reduced activity.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Feldman, Mia S
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~